Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05567575
Other study ID # TechCare-001
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date October 1, 2022
Est. completion date July 31, 2025

Study information

Verified date May 2024
Source Pakistan Institute of Living and Learning
Contact Ameer B Khoso, Mphil
Phone 02135871845
Email ameer.bukhsh@pill.org.pk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Onset of First Episode Psychosis (FEP) is at a young age and is a critical period influencing the long-term course of the disorder. Failure to identify FEP can lead to serious implications such as disruption of education, reduced long-term employment, huge economic burden, and is associated with significantly higher mortality. The prevalence of psychosis increases rapidly from age 14 onwards with a peak incidence in the late teens and early 20s. The aim of the project is to examine the acceptability and feasibility of a mobile phone application-based intervention 'TechCare-PK', for individuals with psychosis in Pakistan. The main objectives are to determine whether appropriate individuals could be identified and recruited to the study and whether the TechCare App would be an acceptable intervention for individuals with psychosis.


Description:

Onset of First Episode Psychosis (FEP) is at a young age and is a critical period influencing the long-term course of the disorder. Failure to identify FEP can lead to serious implications such as disruption of education, reduced long-term employment, huge economic burden, and is associated with significantly higher mortality. The prevalence of psychosis increases rapidly from age 14 onwards with a peak incidence in the late teens and early 20s. The aim of the project is to examine the acceptability and feasibility of a mobile phone application-based intervention 'TechCare-PK', for individuals with psychosis in Pakistan. The main objectives are to determine whether appropriate individuals could be identified and recruited to the study and whether the TechCare App would be an acceptable intervention for individuals with psychosis. Where there are challenges related to distance, inconvenience, being homebound or reluctance to face-to-face interventions, Mobile Health (mHealth) approaches that leverage mobile devices such as cellular phones and smartphones can be used to support healthcare system. Research has found mobile based interventions as highly acceptable to families and may meet carers' needs in respect of information, guidance, professional and emotional support. These services has been considered as a good and easy mode of exchanging information, providing health related education and advice, management of symptoms, to early recognize the complications, giving reassurance and for providing quality services. Methods: Study Design: A multi-center single blind Randomised Controlled Trial (RCT) comparing with Treatment as Usual (TAU) with participants with First Episode Psychosis (FEP) to be recruited from different psychiatric units across four cities in Pakistan i.e., Karachi, Lahore, Hyderabad and Rawalpindi, Pakistan. If required additional centers will be added i.e., Quetta, Multan and Peshawar following proper ethics amendments. Aim The aim of this study is to design, and test culturally adapted mobile based CBT intervention for patients with FEP. Objectives: - Develop and refine an app based intervention (TechCare) based on existing culturally adapted intervention for psychosis, using patient and public involvement. The aim is to improve its potential efficacy, establish acceptability of the refined intervention to potential participants and facilitators and establish mobile app based deliverability of the intervention - To explore the usefulness of TechCare as an acceptable intervention in reducing symptoms of psychosis. - Undertake an internal pilot to establish recruitment and attrition rates, compliance with protocol and acceptability of the trial design to participants. The proposed study will consist of three phases. First phase of study will focus on developing the app based intervention (TechCare) through qualitative work. Second phase will test run the application with 6-8 service users and incorporate suggestions and refinement of intervention and in the third phase we will test it in a randomised controlled trial.


Recruitment information / eligibility

Status Recruiting
Enrollment 100
Est. completion date July 31, 2025
Est. primary completion date December 30, 2024
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - The inclusion criteria for the study will be: - Male and Females patients diagnosed with FEP- Schizophrenia or Schizoaffective disorder. - Over the age of 18 years. - A score of three or more on any of the positive symptoms on the PANSS - A Minimum score of one on the Calgary Depression scale (CDS) - Having smart phone and able to use smart phone functions. - Able to understand written and spoken Urdu. Exclusion Criteria: - Exclusions will be any evidence of organic brain disease, clinically significant concurrent medical illness, learning disability. - unable to use simple functions of an android phone

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Cognitive Behavioral Therapy,
TechCare is based on the intelligent real time therapy (iRTT) conceptual model proposed by Kelly et al. iRTT relates to the use of mobile technologies to deliver interventions such as CBT, extending beyond assessment of symptoms. The intervention is based on the treatment manual developed by David G. Kingdon and Douglas Turkington. The intervention is informed by evidence based cognitive models of psychosis, where the participant is able to choose from a list of pre-selected digital self-help strategies that are personalised to each participant. For example, the App may incorporate the participant's favourite music in the form of multimedia or YouTube links, which are prompted during symptom elevation. Other examples may include psychoeducation, goal setting, problem-solving, etc., based on common self-help strategies in CBT for Psychosis (CBTp).

Locations

Country Name City State
Pakistan Civil Hospital Karachi Sindh
Pakistan Institute of Psychiatry Rawalpindi Punjab

Sponsors (1)

Lead Sponsor Collaborator
Pakistan Institute of Living and Learning

Country where clinical trial is conducted

Pakistan, 

Outcome

Type Measure Description Time frame Safety issue
Primary Feasibility measures Feasibility will be determined by recruitment rates, adherence rate and retention rates. The criterion for success of feasibility is to recruit >50% of eligible participants, adherence rate (number of home assignments completed; > 50%) and retention rate of 70% From baseline to 3rd month (at the end of intervention)
Primary Acceptability measure Acceptability will be determined using participant feedback on the use of app From baseline to 3rd month (at the end of intervention)
Secondary Positive and Negative Syndrome Scale The Scale will indicate the Positive and Negative Syndrome for Schizophrenia that has been comprised of 30 items. The 30 items of semi structured questionnaire will measure positive syndromes, like delusions, hallucinations and conceptual disorganization whereas negative syndromes include passive or apathetic social avoidance and blunted affect. Changes from baseline to week-12
Secondary Psychotic Symptom Rating Scales (PSYRATS) The dimensions of hallucinations and delusions will be measured by a semi structured interview scale . The dimensions of hallucinations and delusions will be measured by a semi structured interview scale Changes from baseline to week-12
Secondary Calgary Depression Scale (CDS) The scale is specially designed to measure the depression for Psychosis, consist of nine items (Addington et al., 1990). CDS will indicate the subjective and qualitative dimensions of depression in Schizophrenia. Changes from baseline to week-12
Secondary The Work and Social Adjustment Scale (WSAS) Five items scale that measures the perceived impairment of social life, relationships, home management, work and private leisure having scores between 0 to 8 that means 0 (no impairment) and 8 (very severe impairment) with a total score of 40 (Mundt, Marks, Shear, & Greist, 2002). Changes from baseline to week-12
Secondary EuroQol-5 Dimensions EQ5-D An instrument measures the health-related quality of life. Quality of life will be measured in five dimensions, including usual activities, anxiety/depression, pain/discomfort, self-care and mobility (Sobocki et al 2007). Changes from baseline to week-12
Secondary Client Service Receipt Inventory (CSRI): We will collect information about the use of other health services (including the informal sector faith healers/Imams) using CSRI. Changes from baseline to week-12
See also
  Status Clinical Trial Phase
Recruiting NCT04929938 - Application of UP for Transdiagnostic Treatment of Emotional Disorders for UHR for Psychosis Patients N/A
Recruiting NCT05863572 - Strengthening Care in Collaboration With People With Lived Experience of Psychosis in Uganda N/A
Completed NCT04277585 - Improving Access to Early Psychosis Coordinated Specialty Care N/A
Recruiting NCT06197048 - Effect of Nutritional Counseling on Anthropometry and Biomarkers in Patients Diagnosed With Schizophrenia/Psychosis or Bipolar Affective Disorder N/A
Completed NCT04284813 - Families With Substance Use and Psychosis: A Pilot Study N/A
Terminated NCT04404712 - FAAH Availability in Psychiatric Disorders: A PET Study Early Phase 1
Recruiting NCT05769933 - Bridging Gaps in the Neuroimaging Puzzle: New Ways to Image Brain Anatomy and Function in Health and Disease Using Electroencephalography and 7 Tesla Magnetic Resonance Imaging
Recruiting NCT04298450 - ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis Intervention N/A
Not yet recruiting NCT05558332 - Youth Nominated Support Team N/A
Not yet recruiting NCT05358457 - Pilot Study to Evaluate the Effectiveness of Online Familiar Metacognitive Training (MCTf) N/A
Not yet recruiting NCT03807388 - ReMindCare App for Patients From First Episode of Psychosis Unit. N/A
Completed NCT02895269 - COllaborative Shared Care to IMprove Psychosis Outcome N/A
Recruiting NCT02622048 - Understanding and Helping Families: Parents With Psychosis N/A
Completed NCT02531243 - Computer-Aided Learning for Managing Stress N/A
Completed NCT02653729 - Cbt for Psychosis and Affect on Psychosis Symptoms Phase 2
Completed NCT02733575 - Compassion Focused Therapy for Distressing Experiences N/A
Not yet recruiting NCT02244970 - Mindfulness RCT for Early Psychosis N/A
Enrolling by invitation NCT01364818 - Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment N/A
Withdrawn NCT00786318 - Ziprasidone vs Standard Therapy for Agitated Patients in the ED Phase 4
Recruiting NCT00722163 - A Randomized Controlled Trial of Individual Therapy for First Episode Psychosis Phase 0